The global nucleic acid isolation and purification market is expected to reach US$ 994 Million by 2022. Rising investment by government and private agencies in the development of novel biotechnological diagnostic techniques and the surging need to understand and characterize microbial diversity are propelling the demand in the market.
| Attribute | Details |
|---|---|
| Nucleic Acid Isolation And Purification Market Estimated Size in 2022 | US$ 994.8 Million |
| Nucleic Acid Isolation And Purification Market Projected Size in 2029 | US$ 1,452.9 Million |
| Nucleic Acid Isolation And Purification Market Historical CAGR (2014 to 2021) | 4.0% |
| Nucleic Acid Isolation And Purification Market Value-based CAGR (2022 to 2029) | 5.6% |
The global nucleic acid isolation and purification market is estimated to create an absolute dollar opportunity of US$ 1,452.9 Million by 2029, exhibiting growth at a CAGR of 5.6% during the forecast period 2022 to 2029.
Future Market Insights (FMI) states that North America and East Asia are anticipated to collectively account for more than half of the global nucleic acid isolation and purification sales by the end of 2029. In terms of product, the DNA extraction and purification kits segment is projected to register rapid growth, accounting for nearly 59.8% of the total demand share in the market through 2022.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 5.34% |
| H1, 2022 Projected | 5.56% |
| H1, 2022 Outlook | 5.46% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (+) 12 ↑ |
The variation between the BPS values observed within this market in H1, 2022 - outlook over H1, 2022 projected reflects a decline of 10 BPS units. However, A positive BPS growth in H1-2022 over H1-2021 by 12 Basis Point Share (BPS) is demonstrated by the nucleic acid isolation and purification market.
Key developments in the market include the adoption of magnetic beads-based nucleic acid purification and nucleic acid extraction filter plate technology.
The market displays a surge in the BPS values owed to the increased commercial extraction of nucleic acids for a propulsive goal to isolate and develop novel therapeutics for infectious disease proliferation around the globe. Growing CRO activities is also contributing factor to this incline in the BPS values.
Conversely, the market observed a negative shift in the BPS values owed to the factor of the high cost of equipment associated with the extraction techniques, as well as the time required for one process setting. However, the growing research sphere for the biopharmaceutical industry shows promising growth for the market during the projected period.
The demand in the global nucleic acid isolation and purification market grew at 4.0% CAGR between 2014 and 2021. Increasing genomics and enzymology-based research activities in the biotechnology sector across prominent economies such as the USA, India, China, and the United Kingdom are expected to bolster the growth in the market.
Nucleic acid isolation and purification is a routine procedure of molecular biology techniques such as sequencing, cloning, sequencing, polymerase chain reaction, and others. These techniques are used for removing insoluble particles by separating soluble materials such as proteins.
Hence, increasing nucleic acid isolation and purification applications in the field of molecular diagnostics, life science research, genetic engineering, and forensics is estimated to favor the growth in the market. As per FMI, the sales of nucleic acid isolation and purification are expected to accelerate at 5.6% CAGR over the forecast period 2022 to 2029.
Principal Consultant
Developments in genetics along with the advent of advanced diagnostics and personalized medicine, especially for the treatment of infectious diseases, cancer, and genetic disorders are favoring the growth in the market.
With the rapid advancement in molecular biology, the utilization of nucleic acid has increased from just the storage of genetic material and protein synthesis to a multitude of healthcare domains such as precision medicine and gene therapy.
Hence, increasing research and development (R&D) activities across the molecular biology sector and growing demand for modern techniques and next-generation sequencing (NGS) are expected to create lucrative growth opportunities in the market.
Also, governments in several countries are increasingly adopting numerous efforts to support bimolecular (R&D) activities to understand and characterize microbial diversity and develop novel molecular diagnostics and therapies for chronic diseases such as cancer. This is expected to further bolster the growth in the market over the coming years.
Collaboration Between Biotechnology Companies to Favor Nucleic Acid Isolation And Purification Market Growth
As per Future Market Insights, the USA is forecast to lead the nucleic acid isolation and purification market in North America over the assessment period.
With rapid development in molecular biotechnology, novel detection techniques and molecular diagnostic represented by nucleic acid hybridization and nucleic acid sequence analysis are becoming increasingly significant in various medical fields. Hence, leading players in the market are focusing on entering into a strategic collaboration to develop novel products.
For instance, in Market 2020, Zymo Research announced entering into collaboration with, a laboratory instruments and solutions provider, Tecan to launch ready-to-use processing products for streamlining DNA and RNA extraction for nucleic acid hybridization. A slew of such product launches is expected to facilitate growth in the USA
Rising Burden of Cancer to Fuel the Demand for Nucleic Acid Isolation and Purification Kits
China is estimated to emerge as a highly remunerative nucleic acid isolation and purification market in East Asia between 2022 and 2029, states FMI.
A significant rise in the prevalence of chronic diseases such as cancer is being witnessed resulting in propelling the demand for associated diagnostics and treatments. For instance, according to Precision Cancer Medicine, approximately 4.6 million new cancer cases were reported across China, showcasing 174 per 100,000 rates of incidence in the year 2020.
Nucleic acid isolation and purification kits are extensively used for the isolation of nucleic acids from cancerous tissues during bimolecular diagnosis to study the DNA and mutation, increasing incidence of cancer in China is estimated to propel the demand in the market.
Increasing Usage in COVID-19 Detection to Bolster Nucleic Acid Isolation and Purification Sales
Since the outbreak of COVID-19, the European Medicine Agency in the United Kingdom is using nucleic acid tests for emergency use for the detection of coronavirus in patients. As nucleic acid isolation and purification kits are used for these diagnostic techniques, the emergence of new variants of coronavirus is estimated to create immense sales opportunities in the United Kingdom market.
In addition to this, the increasing investment by governments and private agencies in nucleic-based clinical diagnostics, and the growing usage of sequencing techniques to identify and diagnose diseases such as cancer, influenza, HIV-AIDS, and others are expected to bolster the sales of nucleic acid isolation and purification in the United Kingdom
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Increasing Application Scope of Nucleic Acid Isolation and Purification Kits to Elevate Market Growth
Future Market Insights reveals that the DNA extraction and purification kits segment is projected to continue dominating the market, accounting for nearly 59.8% of nucleic acid isolation and purification sales through 2029.
The surging application e of DNA extraction and purification kits in biotechnologies companies and academic research institutes to extract the DNA, prevent nucleic acid degradation during preparation, and minimize the presence of contaminants is bolstering sales across the segment.
Growing Usage in Infectious Diseases RNA Purification to Bolster the Demand for Nucleic Acid Isolation and Purification
On the basis of application, the global nucleic acid isolation and purification market is segmented into plasmid isolation and purification, DNA isolation and purification, and RNA isolation and purification. As per FMI, the RNA isolation and purification segment is forecast to register robust growth in the market through 2029.
An increase in nucleic acid isolation and purification used in the diagnosis of infectious diseases such as COVID-19 and purification of mRNA for constructing the cDNA library is favoring growth. In addition, the growing adoption of these kits in the extraction and processing of bacterial and viral RNA is expected to further elevate the sales in the segment.
Focus on New Drug Development to Augment the Sales of Nucleic Acid Isolation and Purification
In terms of end users, the pharmaceutical and biotechnology companies are estimated to collectively account for the dominant share in the nucleic acid isolation and purification market between 2022 and 2029.
The growing adoption of novel technologies for the development of new drugs, vaccines, and treatments by pharmaceutical and biotechnology companies is favoring market growth. As nucleic acid isolation and purification is the initial step for the development of any therapeutics, rising novel drug development activities across China, India, and the USA are projected to favor the growth in the segment.
Leading players operating in the global nucleic acid isolation and purification market are aiming at launching novel products to gain a competitive edge. On the other hand, some of the manufacturers are focusing on adopting inorganic strategies such as partnership, collaboration, and acquisition with other companies to develop novel products. For instance,
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2029 |
| Historical Data Available for | 2014 to 2021 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Covered | USA, Canada, Germany, United Kingdom, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa |
| Key Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | QIAGEN; Thermo Fisher Scientific, Inc.; Illumina, Inc.; F. Hoffmann-La Roche AG; Merck KGaA; Agilent Technologies; Bio-Rad Laboratories, Inc.; Takara Bio, Inc.; Promega Corporation; New England Biolabs; LGC Limited; Abcam plc; Norgen Biotek Corp; AutoGen, Inc.; Biogenuix; PCR Biosystems, Inc.; MagGenome; Apical Scientific Sdn. Bhd; MACHEREY-NAGEL GmbH & Co. KG |
| Report Coverage | Market Forecast, brand share analysis, competition intelligence, Drivers, Restraints, Opportunities and Threats analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The nucleic acid isolation and purification market is expected to surpass a valuation of US$ 994.6 Million in 2022.
The global nucleic acid isolation and purification market grew at a 4.0% CAGR over the past assessment period of 2014 to 2021.
The nucleic acid isolation and purification market is expected to register steady growth, expanding at 5.6% CAGR between 2022 and 2029.
North America currently leads the global nucleic acid isolation and purification market, exhibiting growth at a robust CAGR over the assessment period.
East Asia's nucleic acid isolation and purification market will hold a significant revenue share between 2022 and 2029.
In terms of product, the DNA extraction and purification kits segment is expected to account for maximum sales in the global nucleic acid isolation and purification market through 2029.
1. Executive Summary | Nucleic Acid Isolation and Purification Market
1.1. Global Market Outlook
1.2. Trends
1.3. Major Companies
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Value chain
4.3. Iceberg Analysis
4.4. Pricing Analysis
4.4.1. Pricing Assumptions
4.4.2. Price Projections Per Region
5. Global Market Demand (in Value or Size in US$ Million) Analysis 2014 to 2021 and Forecast, 2022 to 2029
5.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021
5.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Industry Outlook
6.1.3. Income Per Capita Outlook
6.2. Forecast Factors - Relevance & Impact
6.2.1. Technological Advances in Genomics and Proteomics
6.2.2. Rising Nucleic Acid-Based Therapeutics Demand
6.2.3. Increasing R&D in the field of Gene Therapy
6.2.4. Increasing Awareness of Genomic Diagnostics
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Product
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) Analysis By Product Type, 2014 to 2021
7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2022 - 2029
7.3.1. Kits and Reagents
7.3.1.1. DNA Extraction and Purification Kits
7.3.1.1.1. ColuMillion-Based Kits
7.3.1.1.2. Magnetic Beads
7.3.1.1.3. Reagent-Based Kits
7.3.1.2. RNA Extraction and Purification Kits
7.3.1.2.1. ColuMillion-Based Kits
7.3.1.2.2. Magnetic Beads
7.3.1.2.3. Reagent-Based Kits
7.3.1.3. Nucleic Acid Extraction and Purification Kits
7.4. Market Attractiveness Analysis By Product Type
8. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Application
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Application, 2014 to 2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 - 2029
8.3.1. Plasmid Isolation and Purification
8.3.2. DNA Isolation and Purification
8.3.3. RNA Isolation and Purification
8.4. Market Attractiveness Analysis By Application
9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By End User, 2014 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 - 2029
9.3.1. Pharmaceutical Companies
9.3.2. Biotechnology Companies
9.3.3. Contract Research Organizations
9.3.4. Academic Research Institutes
9.4. Market Attractiveness Analysis By End User
10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis By Region, 2014 to 2021
10.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2022 - 2029
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Middle East and Africa (MEA)
10.3.5. East Asia
10.3.6. South Asia
10.3.7. Oceania
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
11.1. Introduction
11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
11.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2021 to 2028
11.3.1. By Country
11.3.1.1. USA
11.3.1.2. Canada
11.3.2. By Product Type
11.3.3. By Application
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product Type
11.4.3. By Application
11.4.4. By End User
11.5. Market Trends
11.6. Key Market Participants - Intensity Mapping
11.7. Drivers and Restraints - Impact Analysis
12. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
12.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2021 to 2028
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Rest of Latin America
12.3.2. By Product Type
12.3.3. By Application
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product Type
12.4.3. By Application
12.4.4. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
13. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
13.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2021 to 2028
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. United Kingdom
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Product Type
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By Application
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
14. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
14.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2021 to 2028
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Product Type
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
15. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
15.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2021 to 2028
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product Type
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By Application
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
16. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
16.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2021 to 2028
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product Type
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
17.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2021 to 2028
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. Northern Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Product Type
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By Application
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Emerging Countries Market Analysis 2014 to 2021 and Forecast 2022 to 2029
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. China Market Analysis
18.2.1. Introduction
18.2.2. PEST Analysis
18.2.3. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy
18.2.3.1. By Product Type
18.2.3.2. By Application
18.2.3.3. By End User
18.3. India Market Analysis
18.3.1. Introduction
18.3.2. PEST Analysis
18.3.3. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy
18.3.3.1. By Product Type
18.3.3.2. By Application
18.3.3.3. By End User
18.4. Brazil Market Analysis
18.4.1. Introduction
18.4.2. PEST Analysis
18.4.3. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy
18.4.3.1. By Product Type
18.4.3.2. By Application
18.4.3.3. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
19.3.1. By Regional footprint of Players
19.3.2. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Deep Dive
20.2.1. Thermo Fisher Scientific, Inc.
20.2.1.1. Overview
20.2.1.2. Product Portfolio
20.2.1.3. Profitability by Market Segments (Product/Channel/Region)
20.2.1.4. Sales Footprint
20.2.1.5. Strategy Overview
20.2.1.5.1. Marketing Strategy
20.2.1.5.2. Product Strategy
20.2.1.5.3. Channel Strategy
20.2.2. Promega Corporation
20.2.2.1. Overview
20.2.2.2. Product Portfolio
20.2.2.3. Profitability by Market Segments (Product/Channel/Region)
20.2.2.4. Sales Footprint
20.2.2.5. Strategy Overview
20.2.2.5.1. Marketing Strategy
20.2.2.5.2. Product Strategy
20.2.2.5.3. Channel Strategy
20.2.3. Agilent Technologies Inc.
20.2.3.1. Overview
20.2.3.2. Product Portfolio
20.2.3.3. Profitability by Market Segments (Product/Channel/Region)
20.2.3.4. Sales Footprint
20.2.3.5. Strategy Overview
20.2.3.5.1. Marketing Strategy
20.2.3.5.2. Product Strategy
20.2.3.5.3. Channel Strategy
20.2.4. Illumina, Inc.
20.2.4.1. Overview
20.2.4.2. Product Portfolio
20.2.4.3. Profitability by Market Segments (Product/Channel/Region)
20.2.4.4. Sales Footprint
20.2.4.5. Strategy Overview
20.2.4.5.1. Marketing Strategy
20.2.4.5.2. Product Strategy
20.2.4.5.3. Channel Strategy
20.2.5. Takara Bio, Inc.
20.2.5.1. Overview
20.2.5.2. Product Portfolio
20.2.5.3. Profitability by Market Segments (Product/Channel/Region)
20.2.5.4. Sales Footprint
20.2.5.5. Strategy Overview
20.2.5.5.1. Marketing Strategy
20.2.5.5.2. Product Strategy
20.2.5.5.3. Channel Strategy
20.2.6. General Electric Company
20.2.6.1. Overview
20.2.6.2. Product Portfolio
20.2.6.3. Profitability by Market Segments (Product/Channel/Region)
20.2.6.4. Sales Footprint
20.2.6.5. Strategy Overview
20.2.6.5.1. Marketing Strategy
20.2.6.5.2. Product Strategy
20.2.6.5.3. Channel Strategy
20.2.7. F. Hoffmann-La Roche AG
20.2.7.1. Overview
20.2.7.2. Product Portfolio
20.2.7.3. Profitability by Market Segments (Product/Channel/Region)
20.2.7.4. Sales Footprint
20.2.7.5. Strategy Overview
20.2.7.5.1. Marketing Strategy
20.2.7.5.2. Product Strategy
20.2.7.5.3. Channel Strategy
20.2.8. Danaher Corporation
20.2.8.1. Overview
20.2.8.2. Product Portfolio
20.2.8.3. Profitability by Market Segments (Product/Channel/Region)
20.2.8.4. Sales Footprint
20.2.8.5. Strategy Overview
20.2.8.5.1. Marketing Strategy
20.2.8.5.2. Product Strategy
20.2.8.5.3. Channel Strategy
20.2.9. QIAGEN
20.2.9.1. Overview
20.2.9.2. Product Portfolio
20.2.9.3. Profitability by Market Segments (Product/Channel/Region)
20.2.9.4. Sales Footprint
20.2.9.5. Strategy Overview
20.2.9.5.1. Marketing Strategy
20.2.9.5.2. Product Strategy
20.2.9.5.3. Channel Strategy
20.2.10. Bio-Rad Laboratories, Inc.
20.2.10.1. Overview
20.2.10.2. Product Portfolio
20.2.10.3. Profitability by Market Segments (Product/Channel/Region)
20.2.10.4. Sales Footprint
20.2.10.5. Strategy Overview
20.2.10.5.1. Marketing Strategy
20.2.10.5.2. Product Strategy
20.2.10.5.3. Channel Strategy
20.2.11. Merck KgaA
20.2.11.1. Overview
20.2.11.2. Product Portfolio
20.2.11.3. Profitability by Market Segments (Product/Channel/Region)
20.2.11.4. Sales Footprint
20.2.11.5. Strategy Overview
20.2.11.5.1. Marketing Strategy
20.2.11.5.2. Product Strategy
20.2.11.5.3. Channel Strategy
20.2.12. New England Biolabs
20.2.12.1. Overview
20.2.12.2. Product Portfolio
20.2.12.3. Profitability by Market Segments (Product/Channel/Region)
20.2.12.4. Sales Footprint
20.2.12.5. Strategy Overview
20.2.12.5.1. Marketing Strategy
20.2.12.5.2. Product Strategy
20.2.12.5.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Nucleic Acid Isolation and Purification Market
